When cost-effective interventions are unaffordable: Integrating cost-effectiveness and budget impact in priority setting for global health programs

A Systematic Review of Cost-Effectiveness Studies Reporting Cost-per-DALY Averted

(2017) Peter J. Neumann et al.   PLoS One

Cost-effectiveness of hepatitis C treatment using generic direct-acting antivirals available in India

(2017) Rakesh Aggarwal et al.   PLoS One

Priority-setting for achieving universal health coverage

(2016) Kalipso Chalkidou et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION

Using Economic Evidence to Set Healthcare Priorities in Low-Income and Lower-Middle-Income Countries: A Systematic Review of Methodological Frameworks

(2016) Virginia Wiseman et al.   HEALTH ECONOMICS

Using Top-down and Bottom-up Costing Approaches in LMICs: The Case for Using Both to Assess the Incremental Costs of New Technologies at Scale

(2016) Lucy Cunnama et al.   HEALTH ECONOMICS

National spending on health by source for 184 countries between 2013 and 2040

(2016) Joseph L Dieleman et al.   LANCET

Resources Required for Cervical Cancer Prevention in Low- and Middle-Income Countries

(2016) Nicole G. Campos et al.   PLoS One

Role of priority setting in implementing universal health coverage

(2016) Yot Teerawattananon et al.   BMJ-British Medical Journal

What does it mean to put new hepatitis C drugs on a list of essential medicines?

(2016) Julian Urrutia et al.   BMJ-British Medical Journal

Prices, Costs, and Affordability of New Medicines for Hepatitis C in 30 Countries: An Economic Analysis

(2016) Swathi Iyengar et al.   PLOS MEDICINE

Role of priority setting in implementing universal health coverage

(2016) Yot Teerawattananon et al.   BMJ-British Medical Journal

What does it mean to put new hepatitis C drugs on a list of essential medicines?

(2016) Julian Urrutia et al.   BMJ-British Medical Journal

The Cost-Effectiveness of Sofosbuvir-Based Regimens for Treatment of Hepatitis C Virus Genotype 2 or 3 Infection

(2015) Benjamin P. Linas et al.   ANNALS OF INTERNAL MEDICINE

Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States

(2015) Soumitri Barua et al.   ANNALS OF INTERNAL MEDICINE

Health and Economic Implications of National Treatment Coverage for Cardiovascular Disease in India: Cost-Effectiveness Analysis

(2015) S. Basu et al.  

Scaling-up essential neuropsychiatric services in Ethiopia: a cost-effectiveness analysis

(2015) Kirsten Bjerkreim Strand et al.   HEALTH POLICY AND PLANNING

Economists' declaration on universal health coverage

(2015) Lawrence H Summers   LANCET

Cost-effectiveness of rotavirus vaccination in Albania

(2015) Albana Ahmeti et al.   VACCINE

Cost-effectiveness analysis of the introduction of the human papillomavirus vaccine in Honduras

(2015) Ida Berenice Molina Aguilar et al.   VACCINE

Health and Economic Implications of National Treatment Coverage for Cardiovascular Disease in India: Cost-Effectiveness Analysis

(2015) S. Basu et al.   Circulation-Cardiovascular Quality and Outcomes

Cost-effectiveness of Xpert MTB/RIF and investing in health care in Africa

(2015) Ivor Langley et al.   Lancet Global Health

Disparity in market prices for hepatitis C virus direct-acting drugs

(2015) Isabelle Andrieux-Meyer et al.   Lancet Global Health

Sofosbuvir-Based Treatment Regimens for Chronic, Genotype 1 Hepatitis C Virus Infection in U.S. Incarcerated Populations

(2014) Shan Liu et al.   ANNALS OF INTERNAL MEDICINE

Universal Public Finance of Tuberculosis Treatment in India: An Extended Cost-Effectiveness Analysis

(2014) Stéphane Verguet et al.   HEALTH ECONOMICS

Cost-Effectiveness of Breast Cancer Control Strategies in Central America: The Cases of Costa Rica and Mexico

(2014) Laurens M. Niëns et al.   PLoS One

Monitoring Progress towards Universal Health Coverage at Country and Global Levels

(2014) Ties Boerma et al.   PLOS MEDICINE

Model-Based Impact and Cost-Effectiveness of Cervical Cancer Prevention in Sub-Saharan Africa

(2013) Jane J. Kim et al.   VACCINE

Cost-effectiveness of human papillomavirus vaccination in low and middle income countries: A systematic review

(2013) Michaela Fesenfeld et al.   VACCINE

Budget Impact Analysis—Principles of Good Practice: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force

(2013) Sean D. Sullivan et al.   VALUE IN HEALTH

Antenatal Syphilis Screening Using Point-of-Care Testing in Sub-Saharan African Countries: A Cost-Effectiveness Analysis

(2013) Andreas Kuznik et al.   PLOS MEDICINE

A Critical Systematic Review of Budget Impact Analyses on Drugs in the EU Countries

(2013) Katelijne van de Vooren et al.   Applied Health Economics and Health Policy

Costs of delivering human papillomavirus vaccination to schoolgirls in Mwanza Region, Tanzania

(2012) Wilm Quentin et al.   BMC Medicine

Population Health Impact and Cost-Effectiveness of Tuberculosis Diagnosis with Xpert MTB/RIF: A Dynamic Simulation and Economic Evaluation

(2012) Nicolas A. Menzies et al.   PLOS MEDICINE

Challenges To Building Capacity For Evidence-Based New Vaccine Policy In Developing Countries

(2011) Jon Kim Andrus et al.   HEALTH AFFAIRS

Health and economic impact of rotavirus vaccination in GAVI-eligible countries

(2010) Sun-Young Kim et al.   BMC PUBLIC HEALTH

International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness?

(2009) Takeru Shiroiwa et al.   HEALTH ECONOMICS

Cost‐Benefit Analysis of a Rotavirus Immunization Program in the Arab Republic of Egypt

(2009) Omayra Ortega et al.   JOURNAL OF INFECTIOUS DISEASES

Cost-Effectiveness of New-Generation Oral Cholera Vaccines: A Multisite Analysis

(2009) Marc Jeuland et al.   VALUE IN HEALTH

Guidelines for Conducting Pharmaceutical Budget Impact Analyses for Submission to Public Drug Plans in Canada

(2008) Deborah A Marshall et al.   PHARMACOECONOMICS